15.70 USD
↘ 1.32 (7.76%)AT CLOSE (11:59 AM EDT)
Shares of BioAge Labs, Inc. Common Stock (BIOA) are trading at $15.70. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, BIOA trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 5, 2026.